DALLAS, April 23 /PRNewswire-USNewswire/ -- The American Heart Association is pleased to announce the premiere publication of Circulation: Arrhythmia and Electrophysiology. The new title is the first of a planned extension of the weekly flagship journal, Circulation: Journal of the American Heart Association, consisting of six new journals dedicated to presenting the most important papers in key subspecialty areas of cardiology. The journals will be published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
William Gregory Stevenson, M.D., director of the clinical cardiac electrophysiology program at Brigham and Women's Hospital and professor of medicine at Harvard Medical School, will serve as Editor of Circulation: Arrhythmia and Electrophysiology.
"Our journal will provide a source of high quality articles focusing on advances in our understanding of the pathophysiology, diagnosis and treatment of cardiac arrhythmias," said Stevenson, who also is an associate editor for Circulation: Journal of the American Heart Association.
"As an associate editor, I have been confronted with a large number of investigations that were important and novel for the arrhythmia specialist, but in competition with studies from other disciplines in cardiology, could not be assigned sufficient priority for publication in Circulation," Stevenson said. "Circulation: Arrhythmia and Electrophysiology will provide an extended format for these important studies, as well as presenting a platform for airing reviews and highlighting controversies at the cutting edge of the field."
"I am delighted by the release of this first member of the Circulation portfolio of cardiovascular subspecialty journals, and with its new editor, Dr. Bill Stevenson. Under his very able leadership, the journal will no doubt become a primary source of the latest information in the field of arrhythmias and electrophysiology for the cardiology community," said Joseph Loscalzo, M.D., Editor-in-Chief of Circulation and the Circulation subspecialty journal family.
Stevenson says the new bi-monthly journal reflects the rapid evolution of cardiac electrophysiology as a discipline in its own right. Circulation: Arrhythmia and Electrophysiology will present critical new research on topics such as devices for arrhythmia management, catheter ablation, the pathophysiology of the arrhythmia substrate and novel biologic therapies. Commentaries and reviews on topics of special interest, editorials and opinion pieces, and other special features will provide a worldwide forum for all professionals in the field.
Circulation: Arrhythmia and Electrophysiology is the first of the new "Circulation portfolio" of journals, designed to meet the growing demand for tightly focused information in areas at the cutting edge of cardiology. Circulation: Heart Failure will be the second journal to premier in coming weeks. The remaining four titles - Circulation: Cardiovascular Genetics; Circulation: Cardiovascular Imaging; Circulation: Cardiovascular Quality and Outcomes; and Circulation: Cardiovascular Interventions - are scheduled for launch later in 2008.
Each bimonthly issue of Circulation: Arrhythmia and Electrophysiology and the other new journals will be available in both print and online formats. The journal Web site, http://circep.ahajournals.org will also present "Publish Ahead of Print" articles and other online features.
American Heart Association Premium Professional members will have free, full-text access to journal articles through December 31, 2008. The first issue of each of the six new journals will be available to the public for free as sample issues.
About the American Heart Association
Founded in 1924, the American Heart Association is the nation's oldest and largest voluntary health organization dedicated to building healthier lives, free of heart disease and stroke. These diseases, America's No. 1 and No. 3 killers, claim more than 870,000 lives a year. In fiscal year 2006-07 the association invested more than $554 million in research, professional and public education, advocacy and community service programs to help all Americans live longer, healthier lives. To learn more, call 1-800-AHA-USA1 or visit americanheart.org.
About Wolters Kluwer Health
Wolters Kluwer Health (Conshohocken, PA), a division of Wolters Kluwer, is a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons; electronic information providers, such as Ovid Technologies, Medi-Span and ProVation; and pharmaceutical information providers Adis International and Source(R). For more information, visit WKHealth.com.
Wolters Kluwer is a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer has 2006 annual revenues of €3.4 billion, employs approximately 18,450 people worldwide, and maintains operations across Europe, North America, and Asia Pacific. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. For more information, visit WoltersKluwer.com.
|SOURCE American Heart Association|
Copyright©2008 PR Newswire.
All rights reserved